Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,999 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells.
Maxwell T, Lee KS, Kim S, Nam KS. Maxwell T, et al. Int J Oncol. 2018 Apr;52(4):1339-1349. doi: 10.3892/ijo.2018.4271. Epub 2018 Feb 9. Int J Oncol. 2018. PMID: 29436614
Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
Kwon YS, Lee KS, Chun SY, Jang TJ, Nam KS. Kwon YS, et al. Int J Oncol. 2016 Jul;49(1):336-42. doi: 10.3892/ijo.2016.3520. Epub 2016 May 13. Int J Oncol. 2016. PMID: 27176787
Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma.
Chun SY, Kim S, Nam KS, Lee KS. Chun SY, et al. Biomed Pharmacother. 2018 Mar;99:904-912. doi: 10.1016/j.biopha.2018.01.134. Epub 2018 Feb 20. Biomed Pharmacother. 2018. PMID: 29710490
4,999 results
Jump to page
Feedback